Quality is more than a regulatory requirement in the life sciences industry, it is a fundamental driver of patient trust, operational excellence, and long-term success. In the highly regulated environment of clinical trials, even minor quality lapses can have far-reaching consequences, affecting patient safety, data integrity, product development timelines, and organizational reputation.
Regulatory expectations continue to increase across global supply chains, with the U.S. Food and Drug Administration (FDA) issuing thousands of inspection observations each year, many of which relate to quality systems and procedural controls. The American Society for Quality (ASQ) also estimates that quality-related costs can account for 15% to 20% of sales revenue, highlighting the significant operational and financial impact of quality failures. In an industry built on trust, reliability, and compliance, organizations that make quality a core part of their culture are better equipped to manage risk, meet regulatory expectations, and consistently deliver successful outcomes.
At RxSource, a strong quality and compliance culture is at the core of everything we do. It is not simply a function or a set of procedures, it is a shared mindset embedded across the entire organization, guiding how we operate, make decisions, and serve our customers every day.
Our approach to quality is built on a foundation of ownership, accountability, and continuous improvement. Every team member understands their role in maintaining the highest standards, ensuring that quality is not isolated within a single department but integrated into every process and interaction. This collective responsibility enables us to proactively identify risks, implement effective controls, and consistently deliver reliable outcomes.
This commitment is reflected in our track record. We have achieved zero audit failures, a testament to the robustness of our systems and the discipline of our execution. Additionally, 100% of audits have been completed without critical findings, 90% without major findings, and 45% with no observations at all, demonstrating not only compliance but a level of operational excellence that consistently exceeds industry expectations. Equally important is our mindset toward continuous enhancement. We treat every audit, feedback point, and observation as an opportunity to strengthen our processes and further elevate our standards. Rather than reacting to compliance requirements, we anticipate them, ensuring we remain ahead of evolving regulatory expectations and client needs.
Ultimately, our quality and compliance culture is a key differentiator. It provides our clients with confidence that their programs are supported by a partner who prioritizes consistency, transparency, and reliability at every step. It is this unwavering commitment that underpins our ability to deliver with precision, maintain trust, and build long-term partnerships.
Annie Zanolli is the Senior Vice President, QA and Compliance at RxSource. She joined the company 2 years ago and has over 23 years of industry experience.
Last quarter alone, we were able to positively impact the lives of 44,500 patients. Our goal is to improve the lives of 10 million patients in 10 years. Contact us today to learn more about how we can work together to make a meaningful impact.
Contact Us
